Cargando…
A clinical evaluation of the XIENCE V everolimus eluting stent in the treatment of patients with coronary artery disease: Result from Thailand Registry – XIENCE V performance evaluation (THRIVE study)
OBJECTIVE: To evaluate the 2-year clinical outcomes of XIENCE(TM) V everolimus eluting stent (EES) for the treatment of coronary artery disease. BACKGROUND: Percutaneous coronary intervention with a drug eluting stent has become the preferred treatment in patients with coronary artery disease. Evero...
Autores principales: | Kiatchoosakun, Songsak, Pienvichit, Pavit, Kuanprasert, Srun, Suraphakdee, Navin, Phromminikul, Arintaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5414968/ https://www.ncbi.nlm.nih.gov/pubmed/28460763 http://dx.doi.org/10.1016/j.ihj.2016.10.008 |
Ejemplares similares
-
Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V(®))
por: Sheiban, Imad, et al.
Publicado: (2008) -
The everolimus-eluting Xience stent in small vessel disease: bench, clinical, and pathology view
por: Sanchez, Oscar D, et al.
Publicado: (2014) -
Long‐term (beyond 5 years) clinical impact of Xience everolimus‐eluting stent implantation
por: Matsuda, Hiroaki, et al.
Publicado: (2021) -
Clinical outcomes of biodegradable polymer biolimus-eluting BioMatrix stents versus durable polymer everolimus-eluting Xience stents
por: Lee, Da Hyon, et al.
Publicado: (2017) -
A randomized multicenter trial comparing the XIENCE everolimus eluting stent with the CYPHER sirolimus eluting stent in the treatment of female patients with de novo coronary artery lesions: The SPIRIT WOMEN study
por: Franzone, Anna, et al.
Publicado: (2017)